"चरकसंहिता" — @DOIarchive Telegram-kanali

चरकसंहिता

15 Nov 2022, 06:03

In recent years, it has become painfully clear that psychology is facing a “reproducibility crisis,” in which even famous, long-established phenomena—the stuff of textbooks and TED Talks—might not be real.
https://web.archive.org/web/20181119220353/https://www.theatlantic.com/science/archive/2018/11/psychologys-replication-crisis-real/576223/

Psychology’s Replication Crisis Is Running Out of Excuses

Another big project has found that only half of studies can be repeated. And this time, the usual explanations fall flat.

1.1k 1 2 9 2

चरकसंहिता

8 Nov 2022, 10:23

https://bprice.substack.com/p/lab-leak-20

https://archive.fo/lBHph

Lab Leak 2.0

“If a $1000 PhD side project could kill millions of people, we must end viral [gain-of-function research], or it may end us.”

1.1k 1 3 3

चरकसंहिता

8 Nov 2022, 09:54

Schwartz’s Principles of Surgery, 11th ed..pdf

154.8Mb

Schwartz’s Principles of Surgery, 11th ed..pdf

852 1 4

चरकसंहिता

26 Aug 2022, 00:24

SOCH.pdf

740.8Mb

SOCH 3rd ed

1k 0 7

चरकसंहिता

24 Aug 2022, 05:38

Harrison 2022 mobile edition.pdf

220.3Mb

1.1k 0 11 1

चरकसंहिता

22 Aug 2022, 21:30

Kaplan_and_Sadock's_Comprehensive.pdf

154.8Mb

Kaplan and Sadock’s Comprehensive Textbook of Psychiatry 10th ed

1.1k 1 8

चरकसंहिता

22 Aug 2022, 00:39

Kaplan_&_Sadock’s_Synopsis_of_Psychiatry_12th_Edition_2022.pdf

32.1Mb

Kaplan_&_Sadock’s_Synopsis_of_Psychiatry_12th_Edition_2022

1k 1 12 2

चरकसंहिता

21 Aug 2022, 01:45

The Billion Dollar Molecule_ One Company's - Barry Werth.pdf

2.7Mb

839 1 3 5

The Billion-Dollar Molecule is a book by journalist Barry Werth about the founding and early research efforts of the American biotechnology company Vertex Pharmaceuticals, which was founded in 1989 by Joshua Boger and was among the first biotechnology companies to adopt an explicit strategy of rational drug design as opposed to techniques based on combinatorial chemistry.

This book is notable as an inside look at a biotechnology company, and the stresses and marketing pressures on funding research into drug design.
This book is a mixture of finance and technology. In February, 2014, Barry Werth published a follow-on book, The Antidote, that looks at Vertex 20 years later after his original effort.